- Home
- ARQT vs SPNT Comparison
ARQT vs SPNT Comparison
Compare ARQT & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | SPNT |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | Bermuda |
| Employees | N/A | 1099 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARQT | SPNT |
|---|---|---|
| Price | $27.46 | $24.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $34.00 | $27.50 |
| AVG Volume (30 Days) | ★ 1.9M | 929.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | $0.85 |
| Revenue Next Year | $29.39 | $5.85 |
| P/E Ratio | ★ N/A | $5.65 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $13.70 | $17.17 |
| 52 Week High | $31.77 | $25.00 |
Technical Indicators
Market Signals| Indicator | ARQT | SPNT |
|---|---|---|
| Relative Strength Index (RSI) | 62.27 | 63.72 |
| Support Level | $22.09 | $22.18 |
| Resistance Level | $28.80 | N/A |
| Average True Range (ATR) | 1.24 | 0.65 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 51.09 | 83.11 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.